BioAgilytix Labs provides support for the development of Antibody-Drug Conjugates or ?ADCs, including ligand binding and cell based assay development and validation on multiple platforms.
Specifically, the company’s antibody services include labeling of antibody reagents, ADA purification, and oversight of surrogate positive control antibody generation. BioAgilytix Labs’ scientists are experienced in supporting immunogenicity and PK studies in a variety of species including rodents, humans, and nonhuman primates on ELISA, MSD-ECL, and Gyros platforms
2300 Englert Drive
Durham, NC 27713
Web: BioAgilytix Labs
Advertisement #5
